We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




BD Sells Surgical Instrumentation Platform to STERIS

By HospiMedica International staff writers
Posted on 21 Jun 2023
Print article
Image: The divestiture of the surgical instrumentation platform includes V. Mueller, Snowden-Pencer and Genesis branded products (Photo courtesy of BD)
Image: The divestiture of the surgical instrumentation platform includes V. Mueller, Snowden-Pencer and Genesis branded products (Photo courtesy of BD)

Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (Mentor, OH, USA) for USD 540 million. The divestiture includes the transfer of V. Mueller, Snowden-Pencer, and Genesis branded products as well as three manufacturing facilities.

STERIS is a global provider of products and services that support patient care, particularly in the field of infection prevention. It offers a wide range of infection prevention products and other procedural services, mainly aimed at healthcare, pharmaceutical, medical device, and dental clients. The acquisition of BD's surgical instrumentation platform, which complements STERIS's Healthcare segment, will empower STERIS to more effectively meet the product and service demands of hospitals and surgery centers. The platform has three dedicated manufacturing sites and about 20,000 SKUs in its portfolio. The divestment of its Surgical Instrumentation platform aligns with the "Simplify" objective of BD's 2025 strategy and represents a significant move towards streamlining its product portfolio and manufacturing network.

"The Surgical Instrumentation platform has a 120-year legacy of providing reliable and trusted high-quality products, and STERIS is well positioned to maximize the value of this extensive portfolio and is fortunate to be adding such a dedicated and talented team to its organization," said Rick Byrd, president of the Interventional segment at BD. "This transaction further advances the BD Interventional segment's focus on high-growth end markets. We look forward to continuing to address unmet needs in health care through a highly differentiated and innovative set of solutions and products."

Related Links:
Becton, Dickinson and Company 
STERIS 


Print article

Channels

Surgical Techniques

view channel
Image: The PtNGrid features thin, flexible and densely packed grids of either 1,024 or 2,048 embedded ECoG sensors (Photo courtesy of David Baillot/UC San Diego Jacobs School of Engineering)

Electronic Grid Records Brain Activity during Surgery to Minimize Damage to Healthy Tissue

A new electronic grid equipped with nanoscale sensors that records electrical signals from the human brain with unprecedented detail could enhance surgical planning and execution for removing brain tumors... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.